Rapamycin resistance: MTORC1 substrates hold some of the answers

Current Biology

Volumn 23, Issue 19, 2013, Pages

  Yoon, Sang Oh ^a   Roux, Philippe P ^b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PROTEIN; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; ARTICLE; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; HUMANS; PEPTIDES; PROTEINS; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84885206511     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2013.08.030     Document Type: Short Survey

References (20)

1. C.C. Dibble, and B.D. Manning Signal integration by mTORC1 coordinates nutrient input with biosynthetic output Nat. Cell Biol. 15 2013 555 564
2. S.G. Kim, G.R. Buel, and J. Blenis Nutrient regulation of the mTOR complex 1 signaling pathway Mol. Cells 35 2013 463 473
3. D. Benjamin, M. Colombi, C. Moroni, and M.N. Hall Rapamycin passes the torch: a new generation of mTOR inhibitors Nat. Rev. Drug Discov. 10 2011 868 880
4. A.Y. Choo, and J. Blenis Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy Cell Cycle 8 2009 567 572
5. C.C. Thoreen, and D.M. Sabatini Rapamycin inhibits mTORC1, but not completely Autophagy 5 2009 725 726
6. S.A. Kang, M.E. Pacold, C.L. Cervantes, D. Lim, H.J. Lou, K. Ottina, N.S. Gray, B.E. Turk, M.B. Yaffe, and D.M. Sabatini mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin Science 341 2013 1236566
7. H.J. Yang, D.G. Rudge, J.D. Koos, B. Vaidialingam, H.J. Yang, and N.P. Pavletich mTOR kinase structure, mechanism and regulation Nature 497 2013 217 223
8. X.M. Ma, and J. Blenis Molecular mechanisms of mTOR-mediated translational control Nat. Rev. Mol. Cell Biol. 10 2009 307 318
9. K. Duvel, J.L. Yecies, S. Menon, P. Raman, A.I. Lipovsky, A.L. Souza, E. Triantafellow, Q. Ma, R. Gorski, and S. Cleaver Activation of a metabolic gene regulatory network downstream of mTOR complex 1 Mol. Cell 39 2010 171 183
10. S.G. Dann, A. Selvaraj, and G. Thomas mTOR complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer Trends Mol. Med. 13 2007 252 259
11. C. Selman, J.M. Tullet, D. Wieser, E. Irvine, S.J. Lingard, A.I. Choudhury, M. Claret, H. Al-Qassab, D. Carmignac, and F. Ramadani Ribosomal protein S6 kinase 1 signaling regulates mammalian life span Science 326 2009 140 144
12. R.J. Dowling, I. Topisirovic, T. Alain, M. Bidinosti, B.D. Fonseca, E. Petroulakis, X. Wang, O. Larsson, A. Selvaraj, and Y. Liu mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs Science 328 2010 1172 1176
13. B.M. Zid, A.N. Rogers, S.D. Katewa, M.A. Vargas, M.C. Kolipinski, T.A. Lu, S. Benzer, and P. Kapahi 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila Cell 139 2009 149 160
14. P.P. Hsu, S.A. Kang, J. Rameseder, Y. Zhang, K.A. Ottina, D. Lim, T.R. Peterson, Y. Choi, N.S. Gray, and M.B. Yaffe The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling Science 332 2011 1317 1322
15. Y. Yu, S.O. Yoon, G. Poulogiannis, Q. Yang, X.M. Ma, J. Villen, N. Kubica, G.R. Hoffman, L.C. Cantley, and S.P. Gygi Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling Science 332 2011 1322 1326
16. J. Chung, C.J. Kuo, G.R. Crabtree, and J. Blenis Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases Cell 69 1992 1227 1236
17. Y. Zhang, and X.F. Zheng mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors Cell Cycle 11 2012 594 603
18. G.S. Ducker, C.E. Atreya, J.P. Simko, Y.K. Hom, M.R. Matli, C.H. Benes, B. Hann, E.K. Nakakura, E.K. Bergsland, and D.B. Donner Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors Oncogene 2013 10.1038/onc.2013.92
19. Q.B. She, E. Halilovic, Q. Ye, W. Zhen, S. Shirasawa, T. Sasazuki, D.B. Solit, and N. Rosen 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors Cancer Cell 18 2010 39 51
20. S. Shin, L. Wolgamott, J. Tcherkezian, S. Vallabhapurapu, Y. Yu, P.P. Roux, and S.O. Yoon Glycogen synthase kinase-3beta positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1 Oncogene 2013 10.1038/onc.2013.113